Literature DB >> 16014701

Vitamin E and organoselenium prevent the cocarcinogenic activity of arsenite with solar UVR in mouse skin.

Ahmed N Uddin1, Fredric J Burns, Toby G Rossman.   

Abstract

Arsenic-induced carcinogenesis is a worldwide problem for which there is currently limited means for control. Recently, we showed that arsenite in drinking water greatly potentiates solar ultraviolet radiation (UVR) induced skin cancer in mice, at concentrations as low as 1.25 mg/l. In this study, we examined the protective efficacy of vitamin E and 1,4-phenylenebis(methylene)selenocyanate (p-XSC) against tumors induced by UVR and UVR + arsenite. Hairless mice were exposed to UVR alone (1.0 kJ/m(2) x 3 times weekly) or UVR + sodium arsenite (5 mg/l in drinking water) and fed lab chow supplemented or not with vitamin E (RRR-alpha-tocopheryl acetate, 62.5 IU/kg diet) or p-XSC (10 mg/kg) for 26 weeks. The tumor yield for mice receiving UVR alone was 3.6 tumors/mouse and the addition of arsenite to the drinking water increased the yield to 7.0 tumors/mouse (P < 0.005). Vitamin E and p-XSC reduced the tumor yield in mice given UVR + arsenite by 2.1-fold (P < 0.001) and 2-fold (P < 0.002), respectively. Vitamin E, but not p-XSC, reduced the tumor yield induced by UVR alone by 30% (P < 0.05). No significant difference in tumor types or grade of malignancy was observed in mice treated with or without chemopreventives. Immunostaining of mouse skin for 8-oxo-2'-deoxyguanosine (8-oxo-dG) revealed a significant reduction of 8-oxo-dG formation in mice treated with vitamin E or p-XSC compared with those treated with UVR + arsenite. These results show that vitamin E and p-XSC protect strongly against arsenite-induced enhancement of UVR carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014701     DOI: 10.1093/carcin/bgi180

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  17 in total

Review 1.  Arsenic-Induced Carcinogenesis: The Impact of miRNA Dysregulation.

Authors:  Ana P Ferragut Cardoso; Laila Al-Eryani; J Christopher States
Journal:  Toxicol Sci       Date:  2018-10-01       Impact factor: 4.849

Review 2.  Elemental and chemically specific X-ray fluorescence imaging of biological systems.

Authors:  M Jake Pushie; Ingrid J Pickering; Malgorzata Korbas; Mark J Hackett; Graham N George
Journal:  Chem Rev       Date:  2014-08-07       Impact factor: 60.622

Review 3.  Cancer in experimental animals exposed to arsenic and arsenic compounds.

Authors:  Erik J Tokar; Lamia Benbrahim-Tallaa; Jerrold M Ward; Ruth Lunn; Reeder L Sams; Michael P Waalkes
Journal:  Crit Rev Toxicol       Date:  2010-11       Impact factor: 5.635

4.  Transplacental arsenic carcinogenesis in mice.

Authors:  Michael P Waalkes; Jie Liu; Bhalchandra A Diwan
Journal:  Toxicol Appl Pharmacol       Date:  2007-01-12       Impact factor: 4.219

5.  A prospective study of blood selenium levels and the risk of arsenic-related premalignant skin lesions.

Authors:  Yu Chen; Marni Hall; Joseph H Graziano; Vesna Slavkovich; Alexander van Geen; Faruque Parvez; Habibul Ahsan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-02       Impact factor: 4.254

Review 6.  Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium.

Authors:  Konstantin Salnikow; Anatoly Zhitkovich
Journal:  Chem Res Toxicol       Date:  2007-10-30       Impact factor: 3.739

7.  Gene expression levels in normal human lymphoblasts with variable sensitivities to arsenite: identification of GGT1 and NFKBIE expression levels as possible biomarkers of susceptibility.

Authors:  Elena V Komissarova; Ping Li; Ahmed N Uddin; Xuyan Chen; Arthur Nadas; Toby G Rossman
Journal:  Toxicol Appl Pharmacol       Date:  2007-09-15       Impact factor: 4.219

Review 8.  The mechanistic basis of arsenicosis: pathogenesis of skin cancer.

Authors:  Katherine M Hunt; Ritesh K Srivastava; Craig A Elmets; Mohammad Athar
Journal:  Cancer Lett       Date:  2014-08-27       Impact factor: 8.679

9.  Impact of life stage and duration of exposure on arsenic-induced proliferative lesions and neoplasia in C3H mice.

Authors:  Gene J Ahlborn; Gail M Nelson; Rachel D Grindstaff; Michael P Waalkes; Bhalchandra A Diwan; James W Allen; Kirk T Kitchin; R Julian Preston; Araceli Hernandez-Zavala; Blakely Adair; David J Thomas; Don A Delker
Journal:  Toxicology       Date:  2009-05-18       Impact factor: 4.221

10.  Transcriptional changes associated with reduced spontaneous liver tumor incidence in mice chronically exposed to high dose arsenic.

Authors:  Gail M Nelson; Gene J Ahlborn; James W Allen; Hongzu Ren; J Christopher Corton; Michael P Waalkes; Kirk T Kitchin; Bhalchandra A Diwan; Geremy Knapp; Don A Delker
Journal:  Toxicology       Date:  2009-10-12       Impact factor: 4.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.